Year |
Citation |
Score |
2024 |
Henry WS, Müller S, Yang JS, Innes-Gold S, Das S, Reinhardt F, Sigmund K, Phadnis VV, Wan Z, Eaton E, Sampaio JL, Bell GW, Viravalli A, Hammond PT, Kamm RD, et al. Ether lipids influence cancer cell fate by modulating iron uptake. Biorxiv : the Preprint Server For Biology. PMID 38562716 DOI: 10.1101/2024.03.20.585922 |
0.375 |
|
2022 |
Yeary KHK, Quisenberry A, Hall MG, Yu H, Henry WAE, Rodriguez EM, Zoellner JM. Sweet Beverages and Cancer: A Scoping Review of Quantitative Studies. Cancer Prevention Research (Philadelphia, Pa.). PMID 35271710 DOI: 10.1158/1940-6207.CAPR-21-0507 |
0.347 |
|
2020 |
Böpple K, Dong M, Kleih M, Gaißler A, Oren Y, Henry WS, Oren M, Aylon Y, Winkler B, Regev A, Weinberg RA, Kopp H, Aulitzky WE, Essmann F. Abstract 4320: Ovarian cancer persister cells are characterized by enhanced ER stress gene expression correlating with poor survival Endocrinology. DOI: 10.1158/1538-7445.Am2020-4320 |
0.393 |
|
2017 |
Thomas C, Henry W, Cuiffo BG, Collmann AY, Marangoni E, Benhamo V, Bhasin MK, Fan C, Fuhrmann L, Baldwin AS, Perou C, Vincent-Salomon A, Toker A, Karnoub AE. Pentraxin-3 is a PI3K signaling target that promotes stem cell-like traits in basal-like breast cancers. Science Signaling. 10. PMID 28223411 DOI: 10.1126/Scisignal.Aah4674 |
0.606 |
|
2016 |
Henry WS, Laszewski T, Tsang T, Beca F, Beck AH, McAllister SS, Toker A. Aspirin suppresses growth in PI3K-mutant breast cancer by activating AMPK and inhibiting mTORC1 signaling. Cancer Research. PMID 27940576 DOI: 10.1158/0008-5472.Can-16-2400 |
0.665 |
|
2016 |
Henry WS, Hendrickson DG, Beca F, Glass B, Lindahl-Allen M, He L, Ji Z, Struhl K, Beck AH, Rinn JL, Toker A. LINC00520 is induced by Src, STAT3, and PI3K and plays a functional role in breast cancer. Oncotarget. PMID 27626181 DOI: 10.18632/Oncotarget.11962 |
0.637 |
|
2015 |
Kaunisto A, Henry WS, Montaser-Kouhsari L, Jaminet SC, Oh EY, Zhao L, Luo HR, Beck AH, Toker A. NFAT1 promotes intratumoral neutrophil infiltration by regulating IL8 expression in breast cancer. Molecular Oncology. 9: 1140-54. PMID 25735562 DOI: 10.1016/J.Molonc.2015.02.004 |
0.617 |
|
2015 |
Henry W, Toker A. Abstract 2634: Investigating the chemotherapeutic effects of aspirin in mutant PIK3CA breast cancer Cancer Research. 75: 2634-2634. DOI: 10.1158/1538-7445.Am2015-2634 |
0.643 |
|
Show low-probability matches. |